Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 5—May 2020
Synopsis

Surveillance of Leprosy in Kiribati, 1935–2017

Stephen T. ChambersComments to Author , Nabura Ioteba, Eretii Timeon, Erei Rimon, Helen Murdoch, Jared Green, Emma Trowbridge, Jane Buckingham, Arturo Cunanan, Jonathan Williman, and Patricia Priest
Author affiliations: Christchurch Hospital, Christchurch, New Zealand (S.T. Chambers); Pacific Leprosy Foundation, Christchurch (S.T. Chambers, N. Ioteba, P. Priest); University of Otago, Christchurch (S.T. Chambers, J. Williman); Canterbury District Health Board, Canterbury, New Zealand (N. Ioteba); Ministry of Health and Medical Services, Bikenibau, Kiribati (E. Timeon, E. Rimon, H. Murdoch); University of Canterbury, Christchurch (J. Buckingham); Culion Sanatorium and General Hospital, Culion, Philippines (A. Cunanan); University of Otago, Dunedin, New Zealand (P. Priest)

Main Article

Figure 3

Age-specific incidence rates (cases/10,000 population) for multibacillary and paucibacillary leprosy, by age group, Kiribati, 1988–2018. A) Age 0–14 years; B) 15–24 years; C) 25–64 years. Points represent the age-specific rate and vertical lines 95% CIs. Solid lines indicate the locally estimated scatterplot smoothing moving average of age-specific incidence rates of paucibacillary leprosy; dashed lines, of multibacillary leprosy.

Figure 3. Age-specific incidence rates (cases/10,000 population) for multibacillary and paucibacillary leprosy, by age group, Kiribati, 1988–2018. A) Age 0–14 years; B) 15–24 years; C) 25–64 years. Points represent the age-specific rate and vertical lines 95% CIs. Solid lines indicate the locally estimated scatterplot smoothing moving average of age-specific incidence rates of paucibacillary leprosy; dashed lines, of multibacillary leprosy.

Main Article

Page created: April 16, 2020
Page updated: April 16, 2020
Page reviewed: April 16, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external